tiprankstipranks
Trending News
More News >
Dlaboratory Sweden AB (SE:DLAB)
:DLAB

Dlaboratory Sweden AB (DLAB) AI Stock Analysis

Compare
0 Followers

Top Page

SE:DLAB

Dlaboratory Sweden AB

(DLAB)

Select Model
Select Model
Select Model
Neutral 47 (OpenAI - 5.2)
,
Neutral 47 (OpenAI - 5.2)
,
Neutral 47 (OpenAI - 5.2)
,
Neutral 47 (OpenAI - 5.2)
,
Neutral 47 (OpenAI - 5.2)
,
Neutral 47 (OpenAI - 5.2)
,
Neutral 47 (OpenAI - 5.2)
,
Neutral 47 (OpenAI - 5.2)
,
Neutral 47 (OpenAI - 5.2)
Rating:47Neutral
Price Target:
kr2.00
▼(-13.04% Downside)
Action:ReiteratedDate:03/02/26
The score is primarily held back by weak financial performance—continued losses, negative EBIT/EBITDA, and negative gross profit in 2025—despite low leverage and a one-year improvement to positive operating cash flow. Technicals are neutral-to-slightly supportive with price near/above key averages, but valuation lacks support given negative earnings and no dividend data.
Positive Factors
Low leverage / balance-sheet resilience
Near-zero debt materially lowers refinancing and interest risk, giving the company greater financial flexibility during recovery. This durable buffer supports capital allocation to operations or targeted investments without immediate debt-servicing pressure, important amid volatile cash flows.
Improving operating cash generation
A shift to positive operating cash flow signals that core operations can generate liquidity, reducing dependency on external financing if sustained. Over 2–6 months this improvement can fund working capital and small investments, making the business more self-reliant if management maintains discipline.
Revenue scaled since 2020
Higher revenue versus the 2020 baseline indicates underlying market traction and that the business model has scaled to a larger revenue base. This durable customer or demand footprint provides a platform to restore margins through cost control or mix shifts once operational issues are addressed.
Negative Factors
Persistent unprofitability and margin deterioration
Chronic losses and negative operating profitability, capped by a negative gross profit in 2025, point to structural cost or pricing problems. Until gross margins and EBIT/EBITDA sustainably turn positive, the company cannot generate durable earnings or fund growth internally, limiting long-term viability.
Eroding equity and shrinking capital base
A sharply reduced equity base weakens the company’s shock absorbers and reduces capacity for investment or absorbing further losses. Over months this constrains strategic options, may force dilutive financing, and raises governance pressure as available capital to execute recovery diminishes.
Volatile cash flow and weak free cash generation
Inconsistent operating cash and historically negative free cash flow limit the firm’s ability to fund capex, R&D, or bridge losses without external capital. This structural shortfall increases refinancing and dilution risk and undermines the persistence of recent positive operating cash if not steadied.

Dlaboratory Sweden AB (DLAB) vs. iShares MSCI Sweden ETF (EWD)

Dlaboratory Sweden AB Business Overview & Revenue Model

Company DescriptionDlaboratory Sweden AB (publ) operates as a cleantech company in Sweden. It provides dInsight Analytics platform that connects and collects grid data; analyses to unlock critical information; categorizes and visualizes; and transform the information in meaningful context and actionable knowledge. The company was incorporated in 2010 and is based in Lund, Sweden.

Dlaboratory Sweden AB Financial Statement Overview

Summary
Despite materially higher revenue versus 2020, performance has deteriorated recently (revenue down ~17% in 2025). Profitability is a major weakness with persistent net losses, consistently negative EBIT/EBITDA, and 2025 gross profit turning negative. The balance sheet is conservatively levered (near-zero debt), and operating cash flow turned positive in 2025, but cash flow has been volatile and equity has fallen sharply over time.
Income Statement
18
Very Negative
Revenue has scaled materially versus 2020, but the growth path has turned inconsistent recently (down ~17% in 2025 after modest growth in 2024). Profitability remains weak: the company has reported net losses every year from 2020–2025, with EBIT and EBITDA consistently negative. A key red flag is 2025 gross profit turning negative, suggesting sharp cost pressure or adverse mix changes, and it keeps the business far from sustainable earnings power despite earlier periods showing strong gross margins.
Balance Sheet
52
Neutral
Leverage is very conservative (debt is near-zero by 2024–2025), which reduces refinancing risk and provides some balance-sheet resilience. However, equity has fallen sharply from 2021 to 2025, reflecting ongoing losses and limiting financial flexibility over time. Returns on equity have been deeply negative across the available years, and total assets have also trended down since 2021—signs of a shrinking capital base despite low debt.
Cash Flow
33
Negative
Cash generation has been volatile. Operating cash flow was significantly negative through 2020–2024, but turned positive in 2025, which is a constructive shift if it proves repeatable. Free cash flow has generally been negative when disclosed, and 2025 free cash flow is reported at 0, implying limited surplus cash after investments. Overall, cash flow quality is improving but not yet consistently strong enough to offset the history of cash burn.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue44.09M46.78M44.87M45.76M18.05M
Gross Profit-8.29M9.96M36.40M40.20M17.83M
EBITDA-5.94M-3.55M-8.38M-6.44M-14.23M
Net Income-7.65M-6.19M-11.05M-8.99M-16.13M
Balance Sheet
Total Assets20.82M24.65M30.62M37.97M48.20M
Cash, Cash Equivalents and Short-Term Investments5.65M5.74M10.53M14.71M28.16M
Total Debt0.000.00440.00K920.00K1.57M
Total Liabilities17.31M13.48M13.25M9.74M11.32M
Stockholders Equity3.52M11.17M17.37M28.23M36.87M
Cash Flow
Free Cash Flow0.00-3.08M-3.93M-13.15M-12.99M
Operating Cash Flow1.81M-3.08M-3.93M-13.15M-12.80M
Investing Cash Flow-1.88M-1.27M0.000.00-11.96M
Financing Cash Flow-12.00K-440.00K-248.00K-303.00K45.73M

Dlaboratory Sweden AB Technical Analysis

Technical Analysis Sentiment
Positive
Last Price2.30
Price Trends
50DMA
2.48
Negative
100DMA
2.40
Positive
200DMA
2.37
Positive
Market Momentum
MACD
-0.07
Positive
RSI
51.19
Neutral
STOCH
27.49
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:DLAB, the sentiment is Positive. The current price of 2.3 is below the 20-day moving average (MA) of 2.41, below the 50-day MA of 2.48, and below the 200-day MA of 2.37, indicating a neutral trend. The MACD of -0.07 indicates Positive momentum. The RSI at 51.19 is Neutral, neither overbought nor oversold. The STOCH value of 27.49 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:DLAB.

Dlaboratory Sweden AB Peers Comparison

Overall Rating
UnderperformOutperform
Sector (66)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
66
Neutral
$17.65B18.105.60%3.62%6.62%11.55%
47
Neutral
kr41.01M-5.32-177.06%-4.02%6.77%
47
Neutral
kr171.41M-4.23-5.97%-100.00%31.68%
43
Neutral
kr126.48M-1.01-47.34%-36.89%33.50%
* Utilities Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SE:DLAB
Dlaboratory Sweden AB
2.42
-0.36
-12.95%
SE:CLIME.B
Climeon AB
2.48
-0.27
-9.70%
SE:MINEST
Minesto AB
0.66
-1.09
-62.41%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 02, 2026